GRAL – grail, inc. (US:NASDAQ)

News

GRAIL to Participate in Upcoming Investor Conferences
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
GRAIL Reports Third Quarter 2024 Financial Results
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com